Geoff Meacham Analyst PerformanceManaging Director / Global Head of Healthcare at CitigroupGeoff Meacham is a stock analyst at Citigroup focused in the medical sector, covering 45 publicly traded companies. Over the past year, Geoff Meacham has issued 84 stock ratings, including buy and hold recommendations. While full access to Geoff Meacham's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Geoff Meacham's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings156 Last 11 YearsBuy Recommendations61.54% 96 Buy RatingsCompanies Covered45 Unique Companies Ratings Distribution156RatingsDistribution of strong buy, buy, hold, and sell ratings by Geoff Meacham.RatingPercentageCount Strong Buy0.0%0 ratings Buy61.5%96 ratings Hold34.0%53 ratings Sell4.5%7 ratingsOut of 156 total stock ratings issued by Geoff Meacham at Citigroup, the majority (61.5%) have been Buy recommendations, followed by 34.0% Hold and 4.5% Sell.Best & Worst CallsBest Call0000.0%AMLXJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%IPSCJul 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ84.4% of companies on NASDAQ38 companiesNYSE15.6% of companies on NYSE7 companiesGeoff Meacham, an analyst at Citigroup, currently covers 45 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical43 companies95.6%Manufacturing2 companies4.4%Geoff Meacham of Citigroup specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE30 companies66.7%MED - DRUGS6 companies13.3%LARGE CAP PHARMA5 companies11.1%PHARMACEUTICAL PREPARATIONS2 companies4.4%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES1 company2.2%MED - GENERIC DRG1 company2.2% Geoff Meacham's Ratings History at Citigroup Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAPGEApogee Therapeutics6/23/2026Reiterated Rating$132.76$135.00Neutral$0.0000.00% ROIAPGEApogee Therapeutics6/22/2026Downgrade$132.55Hold$0.0000.00% ROITYRATyra Biosciences6/10/2026Boost Price Target$25.94$42.00Buy$0.0000.00% ROIPTCTPTC Therapeutics6/9/2026Upgrade$70.87$108.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/18/2026Downgrade$698.25$700.00Neutral$0.0000.00% ROIMANEVeradermics5/18/2026Boost Price Target$100.35$135.00Buy$0.0000.00% ROIRGNXREGENXBIO5/15/2026Lower Price Target$5.84$14.00Buy$0.0000.00% ROIRPRXRoyalty Pharma5/7/2026Boost Price Target$50.20$66.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics5/6/2026Reiterated Rating$99.21Outperform$0.0000.00% ROIMRKMerck & Co., Inc.5/6/2026Initiated Coverage$113.73$125.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BIIBBiogen5/1/2026Boost Price Target$189.28$200.00Neutral$0.0000.00% ROIPFEPfizer4/29/2026Boost Price Target$26.45$27.00Neutral$0.0000.00% ROIKNSAKiniksa Pharmaceuticals International4/29/2026Boost Price Target$53.27$60.00Buy$0.0000.00% ROIBIIBBiogen4/13/2026Lower Price Target$173.61$190.00Neutral$0.0000.00% ROIGILDGilead Sciences4/13/2026Boost Price Target$137.70$165.00Buy$0.0000.00% ROIMGTXMeiraGTx3/27/2026Boost Price Target$7.49$16.00Buy$0.0000.00% ROIAPGEApogee Therapeutics3/24/2026Boost Price Target$73.35$125.00Buy$0.0000.00% ROIMRKMerck & Co., Inc.3/20/2026Boost Price Target$113.62$125.00Neutral$0.0000.00% ROIPTGXProtagonist Therapeutics3/19/2026Boost Price Target$103.71$125.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical3/11/2026Lower Price Target$60.89$85.00Buy$0.0000.00% ROIBNTXBioNTech3/11/2026Lower Price Target$90.85$130.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals3/10/2026Boost Price Target$502.67$585.00Buy$0.0000.00% ROIGILDGilead Sciences3/6/2026Reiterated Rating$144.40Buy$0.0000.00% ROISRRKScholar Rock3/4/2026Boost Price Target$45.78$58.00Buy$0.0000.00% ROIMANEVeradermics3/2/2026Initiated Coverage$45.70$85.00Buy$0.0000.00% ROIKYMRKymera Therapeutics3/2/2026Boost Price Target$89.87$120.00Buy$0.0000.00% ROIACLXArcellx2/24/2026Downgrade$113.75$115.00Neutral$0.0000.00% ROIAMLXAmylyx Pharmaceuticals2/20/2026Boost Price Target$14.02$19.00Buy$0.0000.00% ROIMRNAModerna2/16/2026Reiterated Rating$42.23Neutral$0.0000.00% ROIBIIBBiogen2/9/2026Boost Price Target$196.18$215.00Neutral$0.0000.00% ROIBMYBristol Myers Squibb2/6/2026Boost Price Target$61.82$64.00Neutral$0.0000.00% ROIAMGNAmgen2/4/2026Boost Price Target$338.59$345.00Neutral$0.0000.00% ROIMRKMerck & Co., Inc.2/4/2026Boost Price Target$119.57$120.00Neutral$0.0000.00% ROIRPRXRoyalty Pharma1/27/2026Boost Price Target$40.47$50.00Buy$0.0000.00% ROIBIIBBiogen1/27/2026Boost Price Target$173.12$185.00Neutral$0.0000.00% ROIGILDGilead Sciences1/27/2026Boost Price Target$137.78$156.00Buy$0.0000.00% ROIMRKMerck & Co., Inc.1/27/2026Boost Price Target$108.01$115.00Neutral$0.0000.00% ROIABBVAbbVie1/27/2026Lower Price Target$225.01$230.00Neutral$0.0000.00% ROICRSPCRISPR Therapeutics1/22/2026Lower Price Target$60.66$89.00Buy$0.0000.00% ROIMRNAModerna1/19/2026Reiterated Rating$41.83Neutral$0.0000.00% ROITicker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.👉 Unlock the ticker now and get it completely free.SRRKScholar Rock1/9/2026Initiated Coverage$41.67$55.00Buy$0.0000.00% ROIVORVor Biopharma1/9/2026Initiated Coverage$12.78$50.00Buy$0.0000.00% ROIBIIBBiogen1/7/2026Boost Price Target$182.61$180.00Neutral$0.0000.00% ROIGILDGilead Sciences1/7/2026Boost Price Target$123.45$140.00Buy$0.0000.00% ROIMRKMerck & Co., Inc.1/7/2026Boost Price Target$108.78$110.00Neutral$0.0000.00% ROIKYMRKymera Therapeutics12/9/2025Boost Price Target$94.30$110.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics12/8/2025Boost Price Target$89.65$115.00Buy$0.0000.00% ROIPFEPfizer12/2/2025Initiated Coverage$25.31$26.00Neutral$0.0000.00% ROIJANXJanux Therapeutics12/2/2025Lower Price Target$33.99$49.00Buy$0.0000.00% ROIABOSAcumen Pharmaceuticals11/18/2025Lower Price Target$1.64$8.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics11/10/2025Boost Price Target$83.23$98.00Buy$0.0000.00% ROIPTCTPTC Therapeutics11/5/2025Boost Price Target$67.72$75.00Neutral$0.0000.00% ROIABBVAbbVie11/3/2025Lower Price Target$218.14$235.00Neutral$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/29/2025Boost Price Target$652.98$700.00Buy$0.0000.00% ROIRNAAvidity Biosciences10/27/2025Downgrade$69.99Hold$0.0000.00% ROIRNAAvidity Biosciences10/27/2025Reiterated Rating$49.15$72.00Buy$0.0000.00% ROIMRNAModerna10/23/2025Lower Price Target$26.85$28.00Neutral$0.0000.00% ROIPTGXProtagonist Therapeutics10/17/2025Boost Price Target$75.73$96.00Buy$0.0000.00% ROINAMSNewAmsterdam Pharma10/17/2025Boost Price Target$36.47$50.00Buy$0.0000.00% ROIKYMRKymera Therapeutics10/17/2025Boost Price Target$60.46$80.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics10/17/2025Boost Price Target$68.43$93.00Buy$0.0000.00% ROIKNSAKiniksa Pharmaceuticals International10/17/2025Boost Price Target$37.92$50.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals10/17/2025Boost Price Target$14.59$20.00Buy$0.0000.00% ROIMRKMerck & Co., Inc.10/13/2025Initiated Coverage$86.02$95.00Neutral$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/13/2025Boost Price Target$553.05$660.00Buy$0.0000.00% ROIGILDGilead Sciences10/8/2025Boost Price Target$116.78$135.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals10/3/2025Boost Price Target$13.29$16.00Buy$0.0000.00% ROIABBVAbbVie10/3/2025Boost Price Target$237.22$251.00Neutral$0.0000.00% ROIVRTXVertex Pharmaceuticals10/2/2025Boost Price Target$408.38$575.00Buy$0.0000.00% ROIBIIBBiogen9/24/2025Reiterated Rating$137.38Neutral$0.0000.00% ROIAMGNAmgen9/24/2025Boost Price Target$286.81$315.00Neutral$0.0000.00% ROIRNAAvidity Biosciences9/15/2025Boost Price Target$40.52$65.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals8/28/2025Boost Price Target$9.47$14.00Buy$0.0000.00% ROIVIRVir Biotechnology8/27/2025Upgrade$4.44$14.00Buy$0.0000.00% ROIABOSAcumen Pharmaceuticals8/25/2025Lower Price Target$1.51$9.00Buy$0.0000.00% ROIAMGNAmgen8/6/2025Boost Price Target$284.67$310.00Neutral$0.0000.00% ROIREGNRegeneron Pharmaceuticals8/1/2025Reiterated Rating$545.46$650.00Buy$0.0000.00% ROIMRNAModerna8/1/2025Initiated Coverage$29.56$40.00Neutral$0.0000.00% ROIBIIBBiogen8/1/2025Boost Price Target$131.95$135.00Neutral$0.0000.00% ROIPTCTPTC Therapeutics7/28/2025Boost Price Target$44.96$50.00Neutral$0.0000.00% ROIRPRXRoyalty Pharma7/22/2025Boost Price Target$35.64$42.00Buy$0.0000.00% ROIAMGNAmgen7/22/2025Boost Price Target$302.13$305.00Neutral$0.0000.00% ROICRSPCRISPR Therapeutics7/22/2025Lower Price Target$64.51$78.00Buy$0.0000.00% ROIBBIOBridgeBio Pharma6/25/2025Boost Price Target$44.79$54.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics6/17/2025Initiated Coverage$54.66$72.00Buy$000.0000.00% ROINAMSNewAmsterdam Pharma6/17/2025Initiated Coverage$19.75$42.00Buy$00.0000.00% ROIACLXArcellx6/17/2025Initiated Coverage$64.09$110.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals6/17/2025Initiated Coverage$5.44$12.00Buy$00.0000.00% ROIABOSAcumen Pharmaceuticals6/17/2025Initiated Coverage$1.14$4.00Buy$0.0000.00% ROINVAXNovavax6/17/2025Initiated Coverage$7.03$6.00Sell$0.0000.00% ROIPH: Do THESE 4 things to your bank account now … (Ad)In a few short months, the US government could gain unprecedented powers over personal bank accounts - including the ability to track every transaction or freeze funds. Martin D. Weiss, PhD, founder of Weiss Ratings, has identified 4 simple steps Americans can take today to help safeguard their savings before any changes take effect.Discover all 4 steps to help protect your bank account nowRNAAvidity Biosciences6/9/2025Boost Price Target$33.43$54.00Buy$00.0000.00% ROIABBVAbbVie5/14/2025Reiterated Rating$187.95$205.00Neutral$000.0000.00% ROIKYMRKymera Therapeutics5/12/2025Lower Price Target$31.92$44.00Neutral$00.0000.00% ROIPTCTPTC Therapeutics5/7/2025Upgrade$36.19$40.00Neutral$00.0000.00% ROINMRANeumora Therapeutics4/2/2025Reiterated Rating$0.91$1.00Underperform$0.0000.00% ROIETNB89BIO3/13/2025Initiated Coverage$8.35$25.00Buy$0.0000.00% ROIAPGEApogee Therapeutics3/13/2025Initiated Coverage$38.53$95.00Buy$00.0000.00% ROIBNTXBioNTech3/13/2025Initiated Coverage$100.31$145.00Buy$00.0000.00% ROIKNSAKiniksa Pharmaceuticals International3/13/2025Initiated Coverage$22.50$40.00Buy$00.0000.00% ROIRNAAvidity Biosciences3/13/2025Initiated Coverage$32.61$70.00Buy$00.0000.00% ROIKYMRKymera Therapeutics3/13/2025Initiated Coverage$35.10$52.00Buy$00.0000.00% ROIMRNAModerna3/13/2025Initiated Coverage$35.01$40.00Neutral$00.0000.00% ROIRNAAvidity Biosciences3/10/2025Lower Price Target$30.22$48.00Buy$00.0000.00% ROIBMRNBioMarin Pharmaceutical2/20/2025Boost Price Target$65.61$103.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
